PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule

Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

(2014) Bogdan Mitran et al.   AMINO ACIDS

Comparison of Two Site-Specifically 18F-Labeled Affibodies for PET Imaging of EGFR Positive Tumors

(2014) Xinhui Su et al.   MOLECULAR PHARMACEUTICS

The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer

(2013) Minoru Haisa   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer

(2013) Pushpendra Singh et al.   MEDICAL ONCOLOGY

Targeting the insulin-like growth factor-1 receptor in human cancer

(2013) Alexandre Arcaro   Frontiers in Pharmacology

The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology

(2012) M. Pollak   CLINICAL CANCER RESEARCH

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

(2012) Mengzhu Xue et al.   CURRENT PHARMACEUTICAL DESIGN

[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

(2012) Anna Orlova et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PET of EGFR Expression with an 18F-Labeled Affibody Molecule

(2012) Z. Miao et al.   JOURNAL OF NUCLEAR MEDICINE

In vivo targeting of HER2-positive tumor using 2-helix affibody molecules

(2011) Gang Ren et al.   AMINO ACIDS

Evaluation of64Cu-Labeled Bifunctional Chelate–Bombesin Conjugates

(2011) Samia Ait-Mohand et al.   BIOCONJUGATE CHEMISTRY

Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507

(2011) E. D. G. Fleuren et al.   CLINICAL CANCER RESEARCH

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551

(2011) V. Tolmachev et al.   JOURNAL OF NUCLEAR MEDICINE

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review

(2011) Emine Elif Ozkan   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Positron Emission Tomography Imaging of CD105 Expression with a 64Cu-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA

(2011) Yin Zhang et al.   PLoS One

Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Positive Tumor with a64Cu Labeled Affibody Protein

(2010) Zheng Miao et al.   BIOCONJUGATE CHEMISTRY

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

(2010) Vladimir Tolmachev et al.   LANCET ONCOLOGY

Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer

(2009) J. Zha et al.   MOLECULAR CANCER THERAPEUTICS

64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors

(2009) Zhen Cheng et al.   MOLECULAR IMAGING AND BIOLOGY

High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)

(2009) Yixuan Gong et al.   PLoS One

Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments

(2008) E. Vegt et al.   JOURNAL OF NUCLEAR MEDICINE

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of 111In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin)

(2008) Bart Cornelissen et al.   NUCLEAR MEDICINE AND BIOLOGY